StreetAlpha.app
Home › Stocks › PYPD

PolyPid Ltd. (PYPD)

$6.12
▼ −6.56%
LAST CLOSE · NOV 20

PolyPid develops drug candidates that release medicine slowly at the treatment site, led by D-PLEX100 for preventing surgical site infections. It last closed at $6.12 on Nov 20, down 6.56% on the day.

AI Auto Pilots
Is PYPD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PYPD.

Key Stats

Last 12 months
Results
Net income
−$34.2M
Free cash flow
−$28.1M
Balance sheet
Cash & equivalents
$6.4M
At Dec 31
Shareholder equity
$11.0M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$42.6M−$42.6MFY2021FY2022: −$39.6M−$39.6MFY2022FY2023: −$23.9M−$23.9MFY2023FY2024: −$29.0M−$29.0MFY2024FY2025: −$34.2M−$34.2MFY2025

From PYPD's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Feb 25). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on PYPD
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on PYPD

Technical Analysis

PYPD · as of the Nov 20 close · updated each morning
Uptrend

The stock is 2% above its 20 day and 10% above its 50 day average. It is 21% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 55). The nearest support is the swing low (Nov 16) at $6.03, and the nearest resistance the Pivot at $6.32.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 7.4%/day
Key levels
$7.2552 week high+18.5%
$7.15Swing high (Nov 11)+16.8%
$6.56Pivot R1+7.2%
$6.32Pivot+3.3%
$6.12Last close
$6.03Swing low (Nov 16)−1.5%
$6.0020 day average−2.0%
$5.89Pivot S1−3.8%
$5.4850 day average−10.5%
$5.18100 day average−15.4%
$4.84200 day average−20.9%
$3.5052 week low−42.8%
Indicators
RSI (14)54.86Middle of its rangeNeutral
MACD0.31Above its signal lineBullish
Stochastic58.2Middle of its rangeNeutral
ADX (14)28.2Trending up
Williams %R-58.5Oversold below −80, overbought above −20Neutral
CCI (20)51.4Oversold below −100, overbought above 100Neutral
Rate of change−0.3%Change over 10 sessionsBearish
ATR (14)$0.45Typical daily range, 7.4% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for PYPD

What happened before

See how PYPD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow PYPD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How PYPD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for PYPDHow many large options trades hit PYPD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

PYPD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼11 buying vs 16 selling
  • ▼Held by funds -4.0 pts
  • ▼Funds holding -8
  • ▲Superinvestors: 2 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2533−24.2%
In funds' top 1001−100.0%
Held by funds14.1%18.0%−4.0 pts
New / increased2 / 914 / 5−42.1%
Reduced / sold out6 / 106 / 0+166.7%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See PYPD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PYPD is in one of them and how their past PYPD trades turned out.

PYPD in the AI portfolios
Loading…

PYPD News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered PYPD in an article yet. Here's the latest on the wider market.

PYPD in the news

About PolyPid

PolyPid is a biopharmaceutical company based in Petach Tikva, Israel. It develops medicines that release drugs slowly and locally at the site of treatment. Its lead product candidate, D-PLEX100, combines its PLEX technology with the antibiotic doxycycline and is placed directly into the surgical site during surgery to help prevent surgical site infections. The company is also developing treatments for metabolic diseases and cancer, and it plans to license its PLEX technology to other drug developers. Its intended users are surgical patients and the hospitals that treat them.

Headquarters
Petach Tikva, Israel